[Thymic carcinoma successfully treated by a combination of intra-arterial infusion chemotherapy and surgery].
A 47-year-old man with thymic carcinoma that had invaded the inner pericardium and adhered to the superior vena cava and right atrium at first operation was treated with intra-arterial infusion chemotherapy (nedaplatin and adriamycin) through the internal thoracic artery. After 2 courses of modified ADOC therapy (nedaplatin, adriamycin, vincristine, and cyclophosphamide), chest computed tomographic (CT) scans revealed a 47% reduction in tumor size. No adverse effects due to the anticancer drugs were observed. Resection of the tumor included part of the upper lobe of the right lung and pericardium. Examination of resected tumor tissue specimens revealed viable cancer cells and extensive fibrosis. The diagnosis was thymic anaplastic carcinoma. We concluded that intra-arterial selective infusion chemotherapy utilizing an ADOC regimen can be of value as a treatment for thymic carcinoma.
Kitami
A
A
Department of Thoracic and Cardiovascular Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
Suzuki
T
T
Kamio
Y
Y
Suzuki
S
S
Hori
G
G
Ueshima
Y
Y
Suzuki
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002277:Carcinoma / Q000628:therapy*; D002945:Cisplatin; D003131:Combined Modality Therapy; D003520:Cyclophosphamide; D004317:Doxorubicin; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D013953:Thymus Neoplasms / Q000628:therapy*; D014750:Vincristine
D009944:Organoplatinum Compounds; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; C053989:nedaplatin; D002945:Cisplatin